Monday, November 21, 2022 8:30 AM to 4:30 PM
Wilentz attorneys will present on topics including the civil litigation track and labor and employment track.
From 10:15am – 12:15pm
Wilentz Shareholder and Co-Chair of the Mass Tort/Class Action group, current Co-Chair of the NJAJ Mass Tort Section, and Past President of NJAJ, Lynne M. Kizis, to co-present “What to Expect in Civil Voir Dire and Strategies for Your Cases” seminar. The panel will discuss how the recent and proposed revisions to our jury selection process will affect how you try your cases.
Also from 10:15am – 12:15pm
Wilentz Shareholder, Co-Chair of the Employment Law group, and Cannabis attorney Tracy Armstrong, and Employment Law group Associate, Stephanie D. Gironda, to present “Are You High? – Representing Employers Who Suspect an Employee is Impaired by Cannabis” seminar. This seminar will review the current status of the law, including an employer’s options if they suspect an employee is impaired and also the rights of an employee who is accused of impairment. It will also look at the current status of the pending legislation and analyze the issues in current cases involving employee impairment.
Each program has been approved by the NJ, PA, and NY Board on Continuing Legal Education of the Supreme Court of New Jersey for 2.4 hours of total CLE credits.
*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance. Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity. Compliance with state marijuana law does not equal compliance with federal law. Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.